Tower Research Capital (TRC)’s Bioceres Crop Solutions BIOX Stock Holding History

Tower Research Capital (TRC)’s Portfolio BIOX Stock Details BIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-410	Closed	-$537	–	5137
2025 Q4	$537	Sell	410 -922	-69%	-$1.48K	﹤0.01%	4878
2025 Q3	$1.88K	Sell	1,332 -3,924	-75%	-$12K	﹤0.01%	4717
2025 Q2	$23.5K	Buy	+5,256	New	+$23.7K	﹤0.01%	3591
2025 Q1	–	Sell	-539	Closed	-$3.28K	–	5208
2024 Q4	$3.28K	Sell	539 -2,617	-83%	-$17.9K	﹤0.01%	4678
2024 Q3	$24.8K	Buy	3,156 +2,484	+370%	+$25.1K	﹤0.01%	3113
2024 Q2	$7.53K	Sell	672 -830	-55%	-$9.7K	﹤0.01%	4456
2024 Q1	$19K	Buy	1,502 +479	+47%	+$6.31K	﹤0.01%	3048
2023 Q4	$14K	Buy	+1,023	New	+$12K	﹤0.01%	3912
2023 Q2	–	Sell	-403	Closed	-$5K	–	6041
2023 Q1	$5K	Sell	403 -724	-64%	-$8.52K	﹤0.01%	4932
2022 Q4	$14K	Buy	1,127 +185	+20%	+$2.4K	﹤0.01%	3490
2022 Q3	$12K	Buy	+942	New	+$11.6K	﹤0.01%	4324

Other funds holding BIOX

Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tower Research Capital (TRC)'s BIOX Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Bioceres Crop Solutions (BIOX) in Q1 2026, closing a stake of 410 shares — an estimated $537 sold.

Tower Research Capital (TRC) first reported a position in BIOX in Q3 2022 and held it in 11 quarters. The position peaked at $24.8K in Q3 2024. 32 funds tracked by Wall St. Rank hold BIOX as of Q1 2026.

Tower Research Capital (TRC) reported no remaining Bioceres Crop Solutions position as of Q1 2026 after selling out during the quarter.
Tower Research Capital (TRC) sold 410 Bioceres Crop Solutions shares in Q1 2026, an estimated $537.
Tower Research Capital (TRC) first reported a position in Bioceres Crop Solutions in Q3 2022 and held it in 11 quarters.
Tower Research Capital (TRC)'s Bioceres Crop Solutions position peaked at $24.8K in Q3 2024.
32 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.